Foundation Medicine to Provide Comprehensive Genomic Profili

The LEADER trial will use the firm's FDA-approved FoundationOne CDx and FoundationOne Liquid CDx comprehensive genomic profiling tests.

Related Keywords

Foundationone Cdx , Foundation Medicine , Drug Administration , Lung Cancer Research Foundation , Lung Cancer Mutation Consortium , Head Of Clinical Development Geoff Oxnard , Actionable Drivers , Early Stage Lung Cancer , Foundationone Liquid , Clinical Development Geoff Oxnard ,